United Therapeutics files two rare pulmonary disease NDAs, sets sights on approvals in 2027Aug 5Quarterly updateralinepagtreprostinil
MannKind reports Q2 2026 results with pediatric Afrezza and Furoscix ReadyFlow approvalsAug 5Quarterly updatefurosemide injection 80 mg/ 10 mlinsulin human
United Therapeutics posts results for terminated Phase 3 ralinepag CPET studyJul 6Trial updateralinepagUnited Therapeutics
Sign inSign in